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Prognostic value of serum creatinine in non-ST-elevation
Aziz Trichine, Hocine Foudad, Ilyes Bouaguel, Rachid Merghit
Hôpital Militaire de Constantine, Cardiologie, Constantine, Algérie
Introduction and objectives: Cardiovascular disease is the main cause of
death in patients with kidney failure.Moreover, the presence of impaired renal
function is an important prognostic factor in patients with heart disease, and is
a determinant of outcome during follow-up. The main aim was to investigate
the relationship between kidney failure at admission and one-year mortality in
patients with Non-ST-elevation acute coronary syndrome.
Patients and methods: We studied 342 consecutive patients admitted in
the military hospital of Constantine and Algiers. The serum creatinine level
and glomerular filtration rate were determined at admission, and classical risk
factors and biochemical markers were assessed. The primary endpoint was all
cause mortality at one year.
Results: Patients who died were older, more frequently had a history of
diabetes or coronary artery disease, were more likely to have heart failure at
admission, had higher troponin-I, myoglobin and creatinine levels, and were
less likely to have dyslipidemia or to be a smoker. Multivariate analysis
showed that the independent predictors of allcause mortality at one year were
age, diabetes, troponin-I level, Killip class >1, male gender, creatinine level,
and glomerular filtration rate. There was a linear correlation between
increased risk and creatinine level.
Conclusions: Creatinine level at admission is one of the most important
covariates in early prognostic stratification in these patients. A high serum cre-
atinine level (or a low glomerular filtration rate) increases the probability of
death due to all causes. The serum creatinine level is, moreover, an inexpen-
sive, easy-touse, and widely available prognostic marker.
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Corrected QT interval prolongation: a new predictor of cardiovascu-
lar risk in patients with non-ST-elevation acute coronary syndrome.
Algerian cohort
Aziz Trichine, Hocine Foudad, Ilyes Bouaguel, Rachid Merghit
Hôpital Militaire de Constantine, Cardiologie, Constantine, Algérie
Introduction and objectives: Recently we reported that prolongation of
the corrected QT (CTc) interval is an independent risk factor in patients with
unstable angina and acute ischemic changes. The aim of this study was to
determine the prognostic value of the corrected QT (CTc) interval in patients
with non-ST-segment elevation acute coronary syndrome who do not exhibit
acute ischemic changes on admission ECG.
Methods: The study included 105 patients with this syndrome. On admis-
sion, a standard 12-lead ECG was recorded, the cardiac troponin-T was mea-
sured and aTIMI (Thrombolysis in Myocardial Infarction) risk score was
calculated. The primary endpoint was the combination of nonfatal acute myo-
cardial infarction, percutaneous or surgical revascularization, and cardiac
death up to 30 days after discharge. Two independent investigators measured
the QT interval manually and the corrected value was derived using Bazett’s
formula. In the statistical analysis, the following cut-off points were used: the
median TIMI risk score, a cardiac troponin-T level of 0.04 ng/mL, and a QTc
of 0.458 s.
Results: Of the 40 patients (38%) who reached the primary endpoint, 32
(80%) had QTc prolongation. Binary logistic regression analysis showed that
QTc prolongation was an independent predictor of the combined endpoint.
Conclusions: This study shows that QTc prolongation is an independent
predictor of cardiovascular risk in patients with non-ST-segment elevation
acute coronary syndrome but without acute ischemic changes on admission
ECG.
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Predictive factors of long-term cardiovascular death and myocardial
infarction after a first myocardial infarction: a 9.6-year follow-up
study in Tunisia
Kais Ouerghi (1), Salem Abdessalem (2), Amani Kallel (2), Riadh Ben
Jemaa (2), Rachid Mechemche (2)
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Introduction: Few studies have examined the incidence of the composite
event cardiovascular death and/or myocardial infarction in long term in
patients who presented with acute coronary syndrome with ST segment eleva-
tion (STEMI) treated with fibrinolysis or percutaneous angioplasty.
Methods: This is a prospective longitudinal trial held between August
1997 and September 2011 in La Rabta Hospital. Between August 1997 and
august 2004, were randomly included 146 patients who had had a first non-
fatal myocardial infarction non-fatal during the first 30 days. After a mean
follow up of 9.6 years, we recorded the composite event cardiovascular death
and/or myocardial infarction.
Results: The total number of patients who developed the composite event
cardiovascular death and/or myocardial infarction was 34 (23.3%). The
average time of occurrence of the composite event is 8.4+/–4.1 years. No fac-
tors of the characteristics of the population were significantly associated with
nonfatal myocardial infarction at 10 years in univariate analysis. Factors sig-
nificantly predictive of the composite event cardiovascular death and/or myo-
cardial infarction at 9.6 years in univariate analysis are the same factors
predictive of cardiovascular death age (p=0.002), diabetes (p=0.01) and mul-
tivessel coronary disease (p=0.05). There is a tendency to correlation of the
composite event at 9.6 years with history of hypertension (p=0.06). In multi-
variate analysis, independent factors predictive of the composite event, cardio-
vascular death and/or myocardial infarction are age >55 years (OR=.53, 95%
CI: 1.97, 36.96, p=0.004), diabetes (OR=4.3, 95% CI: 1.31, 14.15, p=0.016)
and the anterior territory of the myocardial infarction (OR=5.5, 95% CI: 1.02,
29.66, p=0.047).
Conclusion: In our population predictors of the composite event cardio-
vascular death and/or myocardial infarction in the multivariate analysis were
age, anterior territory of the infarction and diabetes. Better control and man-
agement could reduce the long-term mortality.
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TIMI risk score predicts risk of death at ten-year follow-up in STEMI
patients
Kais Ouerghi (1), Salem Abdessalem (2)
Centre Hospitalier de Saintes, Cardiologie, Saintes, France – (2) Hôpital
la Rabta, Tunis, Tunisie
Background: TIMI Risk Score for ST-elevation myocardial infarction
(STEMI) is a score designed for prediction of mortality occuring 30 days after
a STEMI. It was validated in the literature at 1 years and 5 years after STEMI.
Aim: We applied the TIMI risk score to our cohort of STEMI patients
treated in majority with fibrinolysis to validate the possibility to predict
10 years survival.
Methods: TIMI risk score was developed in a cohort of 146 male Tunisian
(mean age 52.4±9 years) hospitalized during the period 1997 to 2004 with
STEMI treated with fibrinolysis in 68 % of patients and non revascularised
early in 32% of patients. STEMI was diagnosed based on typical criteria:
chest pain or ECG changes and rise in creatinin kinase in all patients. We
excluded from the analysis all patients who died during the first 30 days. After
a mean follow up of 9.6 years, we recorded cardiovascular death. TIMI Risk
Score for STEMI was calculated and they were divided into three groups: Low
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risk (0-2 points), medium risk (3-7) and high risk (>7 points). Univariate anal-
ysis was used for statistical analysis.
Results: At the inclusion 94 (65.4%) of our patients had had a low risk
(TIMI between 0 and 2), 48 patients (32.3%) had had an intermediate risk
(TIMI between 3 and 7) and 4 (2.2%) had had a high risk (TIMI between 8
and 14). Median TIMI risk score was 2.3 (ranging from 0 to 11). During
follow-up there were 18 deaths (12.3%). Mortality was 5.7% in the low risk
group, 25.6% in the intermediate risk group and 0% in the high risk group.
Mortality increased significantly with TIMI risk score in patient with TIMI
score < 7 (p=0.01). In patients with TIMI score > 8, our study did not allow
us to draw any conclusions. We calculated Mortality predicted by corrected
TIMI score (Mortality predicted at 1 year – Mortality predicted at 30 days). In
patients with TIMI risk score <7, Mortality at 10 years of follow up was 4.4
more important than corrected mortality predicted at 1 year.
Conclusions: TIMI Risk Score accurately defines the population of
STEMI patients who are at high risk of death not only during the first 30 days,
but also during 10 years of follow-up. This simple score should be included in
the discharge letters because it contains very useful information for further
care.
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Validation and recalibration of the Framingham’s score hard coro-
nary heart disease in a coronary population
Kais Ouerghi (1), Amani Kallel (2), Salem Abdessalem (2), Riadh Ben
Jemaa (2)
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Purpose: The aim of the study was to Validate and to recalibrate the Fram-
ingham’s score Hard coronary heart disease (HCHD score) in a coronary
Tunisian population.
Methods: Baseline data were collected between 1997 and 2004 in 146
patients. We excluded from the analysis all patients who died during the first
30 days of hospitalization. Vital status was checked and causes of death were
obtained in 2011 after a mean follow up of 9.6 years. We also noticed myo-
cardial infarction during the same period. The expected incidence of the com-
posite event cardiovascular death and/or myocardial infarction was calculated
by applying the HCHD equation on the basis of the level of risk factors in dia-
betic and non-diabetic populations and was compared with the observed inci-
dence of the composite event in each group. Correction factor was calculated
for each group. For the risk thresholds 20 % and that determined from the
ROC curve of the HCHD score sensitivity, specificity values ??were calcu-
lated.
Results: The total number of patients who developed the composite event
cardiovascular death and/or myocardial infarction was 34 (23.3%). The
average of HCHD score in our population is 16.2 +/–7.2% with a range from
2 to 30%. The HCHD score is significantly associated with cardiovascular
death event and/or myocardial infarction in our population (p = 0.029). The
correction factor score is 2 in diabetic group, 1.1 in non-diabetics group
and 1.4 for the total population. The relative risk of HCHD score  is
calculated to 1.59 for the composite event cardiovascular death and/or myocar-
dial infarction at 10 years.For the risk threshold for 20%, sensitivity was cal-
culated at 41.11% and specificity at 76.7%.
Conclusion: HCHD score is validated in coronary male Tunisian patients
with and recalibrated using correction factors. Validation on a larger
population and multi-ethnic remains our future desire.
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SYNTAX score is associated with in-hospital mortality as assessed by
GRACE risk score in patients with acute myocardial infarction
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Background: Current guidelines for the management of patients with
acute myocardial infarction (AMI) recommend the GRACE score for risk
stratification with assessment of admission variables. The syntax score
(SS) is a comprehensive angiographic scoring system that is derived enti-
rely from the coronary anatomy and lesion characteristics. We investigated
the relationship between severity of coronary artery disease (CAD)
assessed with SYNTAX Score (SS) and GRACE Score (GS) in patients
with AMI.
Patients and Methods: From the obseRvatoire des Infarctus de Côte
d’Or (RICO) survey, 614 consecutive patients hospitalized for an AMI
from 1st march 2011 to 30 august 2012 and who underwent coronary
angiography were included. Patients were analyzed into 3 tertiles of risk
based on GS.
Results: The tertiles of risk were defined as low (n = 205)(GS<133),
intermediate (n = 204)(GS:133-165), and high risk (n = 205)(GS: >165).
Age and co-morbidities increase gradually with increased GS risk. Also,
the number of diseased vessels on coronary angiography increased across
the tertiles (p<0.001). In-hospital mortality increased from the low to the
highest tertile (0.5%, 2.0% and 11.8%, p<0.001). Patients at high risk had
significantly higher SS values compared with the intermediate and low GS
risk (median (IQR) SS: 13(6-20) vs 9(4-15) vs 7(3-12), respectively,
p<0.001). Moreover, SS was strongly correlated with GS (r=+0.254,
p<0.001), and remained significant in patients with multivessel disease.
By logistic regression analysis, both GS and SS score are significant cor-
relate of hospital mortality (OR(95%CI)1.04(1.02-1.05), p<0.001 and
OR(95%CI) 1.11(1.07-1.15)).
Conclusion: Although SS and GS don’t share any common items, they
are strongly associated for prognostic information. Both scores allow for
an accurate personalized assessment of patient risk.
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Ischemic mitral regurgitation and non-ST-segment elevation acute
myocardial infarction: long-term prognosis in Algerian cohorte
Ilyes Bouaguel, Hocine Foudad, Rachid Merghit, Aziz Trichine
Hôpital Militaire de Constantine, Cardiologie, Constantine, Algérie
Introduction and objectives: Ischemic mitral regurgitation (MR) is a
common complication of acute myocardial infarction and has a negative
impact on prognosis. However, few studies have been carried out on MR after
non-ST-segment elevation acute myocardial infarction (NSTEMI). Our objec-
tive was to investigate the incidence, clinical predictors, and long-term prog-
nostic implications of MR in patients with NSTEMI.
Methods: The prospective study included 165 consecutive patients who
were discharged in functional class I or II after a first NSTEMI. Each under-
went echocardiography during the first week of admission, and patients were
followed up clinically for a median of 2.3 years. The incidence of readmission
for heart failure, unstable angina, reinfarction, death, or all combined (ie, the
combined event or major adverse cardiac event [MACE]) was recorded.
Results: The patients’ mean age was 68 years and 69% were male. The
incidence of MR was 40% (grade I in 45 patients, grade II in 11, grade III in
7, and grade IV in 3). Age, diabetes mellitus, multivessel disease and MR
(HR=2.17; 95% confidence interval, 1.30-3.64; P=.003) were all indepen-
dently associated with a poor long-term prognosis, in terms of MACEs. Even
the milder grades of MR were associated with more events.
Conclusions: In our milieu, MR frequently occurs after NSTEMI. Its pres-
ence together with other unfavorable factors implies a poor long-term prog-
nosis. This is also true for milder grades of MR. Consequently, MR should be
fully assessed and followed-up after NSTEMI in all patients.
